[31-503-pm] Pharmacotherapies (Cancer) 4

Sun. Mar 31, 2024 4:15 PM - 5:15 PM [Room 503] Conference Center 503 (5F)

Chair: Mitsuru Hashimoto, Takuo Hirose

+Add all to schedule

4:15 PM - 4:27 PM

[31-503-pm01] Relation between COP-NLR and prognosis of patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy.

○Saeko Kashimura¹, Miki Sato¹, Takahito Inagaki², Masaoki Kin³, Ryo Manabe⁴, Sojiro Kusumoto⁴, Atsushi Horiike⁵, Takuya Tsunoda⁵, Mari Kogo¹ (1. Sch. Pharm., Showa Univ., 2. Pharm., Showa Univ. Northern Yokohama Hospital., 3. Pharm., Showa Univ. Hospital, 4. Respirology and Allergology, Sch. Med., Showa Univ., 5. Medical Oncology, Sch. Med., Showa Univ.)

4:27 PM - 4:39 PM

[31-503-pm02S] Analysis of the effects of clone differences in anti-PD-L1 antibodies on anaphylaxis

○Ruiheng Tang¹, Riho Kume¹, Takahiro Arai¹, Rin Miyajima², Hitomi Manaka², Tomomi Kokubo¹, Yuta Tamemoto¹, Kyohei Higashi², Hiroto Hatakeyama¹ (1. Grad. Sch. Pharm. Sci., Chiba Univ., 2. Grad. Sch. Pharm. Sci., Tokyo University of Science)

4:39 PM - 4:51 PM

[31-503-pm03] Prevention of Acne-Like Eruption Caused by Panitumumab Treatment through Oral Administration of Non-steroidal Anti-inflammatory Drugs

○Rei Tanaka^1,2,3, Hiroshi Ishikawa², Junya Sato¹, Takao Aoyama³, Yoshiaki Shikamura³, Michiro Shino² (1. Faculty of Pharmaceutical Sciences, Shonan university of medical sciences, 2. Department of Pharmacy, Shizuoka Cancer Center, 3. Faculty of Pharmaceutical Sciences, Tokyo University of Science)

4:51 PM - 5:03 PM

[31-503-pm04] Development of the management for lung cancer patients treated with immune checkpoint inhibitors

○Satoko Handa¹, Ayane Tsuji¹, Hiroo Ishida², Kenichi Fujita¹ (1. Showa Univ., 2. Showa Univ. Northern Yokohama Hospital)

5:03 PM - 5:15 PM

[31-503-pm05] Health Related Quality of life survey during the introduction of Breast Cancer Patient Participatory Medical Cooperation Support System in breast cancer hormone therapy

○Shinji Takayama¹, Yuko Tanaka², Risa Kasahara³, Reika In⁴, Yasue Tsuchida⁵, Seigo Nakamura^3,5, Hideko Yamauchi⁶, Atsushi Yoshida³, Kazumi Goto¹, Naoki Hayashi^3,5 (1. Dep. Pharm., St. Luke's International Hospital, 2. Dep. Nurse., St. Luke's International Hospital, 3. Dep. Breast Surgical Oncology, St. Luke's International Hospital, 4. mammaira tsukiji, 5. Division of Breast Surgical Oncology, Showa Univ., 6. University of Hawaii, Cancer Center)

Session information